1. The comparative risks and benefits of antidepressants

   Newsletter Article 17 February 2013 Pages: 2 - 3

2. Digoxin interactions

   Newsletter Article 17 February 2013 Pages: 3 - 3

3. Management of benzodiazepine withdrawal

   Newsletter Article 17 February 2013 Pages: 3 - 4

4. Postmarketing surveillance of ranitidine

   Newsletter Article 17 February 2013 Pages: 4 - 4

5. Aciclovir

   Newsletter Article 17 February 2013 Pages: 4 - 4

6. Amoxapine overdose

   Newsletter Article 17 February 2013 Pages: 4 - 4

7. Antituberculars

   Newsletter Article 17 February 2013 Pages: 5 - 5

8. Aspirin/ibuprofen/oxaprozin

   Newsletter Article 17 February 2013 Pages: 5 - 5

9. Captopril

   Newsletter Article 17 February 2013 Pages: 5 - 5

10. Carbamazepine

    Newsletter Article 17 February 2013 Pages: 5 - 5

11. Carbamazepine see Verapamil interaction

    Newsletter Article 17 February 2013 Pages: 5 - 5

12. Chloroquine

    Newsletter Article 17 February 2013 Pages: 5 - 5

13. Cibenzoline

    Newsletter Article 17 February 2013 Pages: 5 - 5

14. Cisplatin

    Newsletter Article 17 February 2013 Pages: 5 - 6

15. Cocaine see Tetracaine/epinephrine/cocaine

    Newsletter Article 17 February 2013 Pages: 6 - 6

16. Cocaine abuse

    Newsletter Article 17 February 2013 Pages: 6 - 6

17. Corticosteroids

    Newsletter Article 17 February 2013 Pages: 6 - 6

18. Cotrimoxazole

    Newsletter Article 17 February 2013 Pages: 6 - 6

19. Dantron

    Newsletter Article 17 February 2013 Pages: 6 - 6

20. Diamorphine

    Newsletter Article 17 February 2013 Pages: 6 - 6

21. Dibrompropamidine

    Newsletter Article 17 February 2013 Pages: 6 - 6

22. Digoxin interaction

    Newsletter Article 17 February 2013 Pages: 6 - 6

23. Disopyramide

    Newsletter Article 17 February 2013 Pages: 6 - 7

24. Enalapril

    Newsletter Article 17 February 2013 Pages: 7 - 7

25. Enoxacin

    Newsletter Article 17 February 2013 Pages: 7 - 7

26. Epinephrine see Tetracaine/epinephrine/cocaine

    Newsletter Article 17 February 2013 Pages: 7 - 7

27. Flecainide

    Newsletter Article 17 February 2013 Pages: 7 - 7

28. Fructose

    Newsletter Article 17 February 2013 Pages: 7 - 7

29. Haloperidol

    Newsletter Article 17 February 2013 Pages: 7 - 7

30. Ibuprofen see Aspirin/ibuprofen/oxaprozin

    Newsletter Article 17 February 2013 Pages: 7 - 7

31. Ifosfamide interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

32. Iohexol/meglumine metrizoate

    Newsletter Article 17 February 2013 Pages: 8 - 8

33. Ivermectin

    Newsletter Article 17 February 2013 Pages: 8 - 8

34. Lithium

    Newsletter Article 17 February 2013 Pages: 8 - 8

35. Meglumine metrizoate see Iohexol/meglumine metrizoate

    Newsletter Article 17 February 2013 Pages: 8 - 8

36. Methyldopa

    Newsletter Article 17 February 2013 Pages: 8 - 9

37. Mitomycin

    Newsletter Article 17 February 2013 Pages: 9 - 9

38. Morphine

    Newsletter Article 17 February 2013 Pages: 9 - 9

39. Ofloxacin

    Newsletter Article 17 February 2013 Pages: 9 - 9

40. Oxaprozin see Aspirin/ibuprofen/oxaprozin

    Newsletter Article 17 February 2013 Pages: 9 - 9

41. Penicillamine

    Newsletter Article 17 February 2013 Pages: 9 - 10

42. Phenobarbital see Ifosfamide interaction

    Newsletter Article 17 February 2013 Pages: 10 - 10

43. Propafenone overdose

    Newsletter Article 17 February 2013 Pages: 10 - 10

44. Protamine sulfate

    Newsletter Article 17 February 2013 Pages: 10 - 10

45. Quinidine ethylphenylbarbiturate

    Newsletter Article 17 February 2013 Pages: 10 - 10

46. Tetracaine/epinephrine/cocaine

    Newsletter Article 17 February 2013 Pages: 10 - 11

47. Theophylline overdose

    Newsletter Article 17 February 2013 Pages: 11 - 11

48. Triazolam

    Newsletter Article 17 February 2013 Pages: 11 - 11

49. Trimethoprim

    Newsletter Article 17 February 2013 Pages: 11 - 11

50. Valproic acid

    Newsletter Article 17 February 2013 Pages: 11 - 11